We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$8.8B
AUM Growth
-$819M
Cap. Flow
-$1.49B
Cap. Flow %
-16.94%
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126
Avg Time Held Equity + Options
3.2 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.7 quarters
Avg Time Held Equity only
3.2 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.7 quarters

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 19.77%
3 Healthcare 15.9%
4 Miscellaneous 8.89%
5 Real Estate 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZNTL icon
801
Zentalis Pharmaceuticals
ZNTL
$227M
$293K ﹤0.01%
13,527
-65,600
-83% -$1.79M
2022 Q1
2 quarters
LAMR icon
802
PUT
Lamar Advertising Co
LAMR
$14.9B
$280K ﹤0.01%
+220,000
New +$21M
2022 Q3
0 quarters
PRAX icon
803
Praxis Precision Medicines
PRAX
$6.79B
$263K ﹤0.01%
7,718
-6,667
-46% -$332K
2022 Q1
2 quarters
CPAAW
804
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$257K ﹤0.01%
1,012,165
-103,516
-9% -$25.6K
2021 Q4
3 quarters
THC icon
805
PUT
Tenet Healthcare
THC
$21.5B
$252K ﹤0.01%
50,000
-63,100
-56% -$3.74M
2021 Q4
3 quarters
SHAK icon
806
PUT
Shake Shack
SHAK
$2.87B
$250K ﹤0.01%
+50,000
New +$2.4M
2022 Q3
0 quarters
CPRI icon
807
PUT
Capri Holdings
CPRI
$1.72B
$247K ﹤0.01%
21,300
– –
2021 Q2
5 quarters
UBX icon
808
DELISTED
Unity Biotechnology
UBX
$240K ﹤0.01%
+60,650
New +$383K
2022 Q3
0 quarters
OMF icon
809
PUT
OneMain Financial
OMF
$6.45B
$235K ﹤0.01%
+27,900
New +$1.03M
2022 Q3
0 quarters
CPE
810
PUT
DELISTED
Callon Petroleum Company
CPE
$232K ﹤0.01%
78,700
– –
2021 Q2
5 quarters
AURA icon
811
Aura Biosciences
AURA
$650M
$225K ﹤0.01%
12,430
-78,109
-86% -$1.18M
2022 Q1
2 quarters
AXSM icon
812
Axsome Therapeutics
AXSM
$8.19B
$223K ﹤0.01%
5,000
-23,026
-82% -$1.15M
2022 Q1
2 quarters
SAVE icon
813
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$216K ﹤0.01%
+100,000
New +$2.35M
2022 Q3
0 quarters
ORTX
814
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$216K ﹤0.01%
43,298
-66,094
-60% -$368K
2022 Q1
2 quarters
DCPH icon
815
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$185K ﹤0.01%
+10,000
New +$157K
2022 Q3
0 quarters
ADT icon
816
PUT
ADT
ADT
$4.83B
$182K ﹤0.01%
90,300
– –
2021 Q2
5 quarters
AMPX.WS icon
817
Amprius Technologies Warrants
AMPX.WS
$286M
$150K ﹤0.01%
+485,383
New +$183K
2022 Q3
0 quarters
MAR icon
818
PUT
Marriott International
MAR
$96.9B
$135K ﹤0.01%
11,000
– –
2022 Q1
2 quarters
HLT icon
819
PUT
Hilton Worldwide
HLT
$74.2B
$107K ﹤0.01%
13,500
– –
2022 Q1
2 quarters
NGL icon
820
PUT
NGL Energy Partners
NGL
$1.87B
$98K ﹤0.01%
81,300
– –
2021 Q2
5 quarters
TCRR
821
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$97K ﹤0.01%
+54,035
New +$157K
2022 Q3
0 quarters
WTI icon
822
PUT
W&T Offshore
WTI
$578M
$95K ﹤0.01%
1,580,400
– –
2021 Q2
5 quarters
VICI icon
823
PUT
VICI Properties
VICI
$25.2B
$89K ﹤0.01%
+25,000
New +$825K
2022 Q3
0 quarters
DKNG icon
824
PUT
DraftKings
DKNG
$9.79B
$86K ﹤0.01%
100,000
+40,000
+67% +$636K
2022 Q1
2 quarters
HPX.WS
825
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$81K ﹤0.01%
261,507
– –
2022 Q1
2 quarters

Similar funds

UBS O'Connor's Q3 2022 Portfolio in Review

As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

UBS O'Connor withdrew a net $1.49B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.

  • UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
  • UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
  • UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
  • UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
  • UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
  • UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
  • UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.